C-TTI

V:TTI - Thiogenesis Therapeutics, Corp. - https://www.thiogenesis.com

00:44:10 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
TTI - V	0.5	0.55	·	0.60	1.5	0.55	+0.03	5.8	185.0	105	24	0.56 0.62 0.55	0.83 0.51	15:28:46	Feb 20	15 min RT 2¢
TSX-V - V	0.5	0.55	·	0.60	1.5	0.55	+0.03	5.8	160.0	90	18	0.56 0.62 0.55	0.83 0.51	15:28:46		15 min
NEO ATS - U						0.55	+0.03	5.8	22.0	13	4	0.60 0.60 0.55		14:38:41		15 min
Omega - O						0.55	+0.03	5.8	2.0	1	1	0.55 0.55 0.55		14:38:41		15 min
CX2 - H						0.55	+0.03	5.8	1.0	1	1	0.55 0.55 0.55		14:38:41		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 24

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:28:46	V	0.55	0.03	3,000	68 Leede	1 Anonymous	K
14:38:41	O	0.55	0.03	2,000	1 Anonymous	1 Anonymous	K
14:38:41	H	0.55	0.03	1,000	1 Anonymous	1 Anonymous	K
14:38:41	U	0.55	0.03	6,000	1 Anonymous	1 Anonymous	K
14:38:41	V	0.55	0.03	21,000	68 Leede	1 Anonymous	K
14:38:41	U	0.55	0.03	6,000	1 Anonymous	1 Anonymous	K
14:17:43	V	0.60	0.08	1,000	13 Instinet	19 Desjardins	K
13:25:50	V	0.55	0.03	25,500	68 Leede	1 Anonymous	K
13:25:50	V	0.56	0.04	5,500	79 CIBC	1 Anonymous	K
13:25:50	V	0.58	0.06	2,500	19 Desjardins	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2025-02-20 18:08	C:TTI	0.74	News Release200	Thiogenesis hires Bull Markets for IR in Europe
2025-02-12 11:24	C:TTI	0.64	News Release200	Thiogenesis Therapeutics lists on OTCQX Best Market
2025-02-12 07:00	C:TTI	0.64	News Release200	OTC Markets Group Welcomes Thiogenesis Therapeutics, Corp. to OTCQX
2025-01-27 18:07	C:TTI	0.64	News Release200	Thiogenesis receives European OK for phase 2 trial
2024-12-10 09:01	C:TTI	0.60	News Release200	Thiogenesis Announces Presentation on UMDF Webcast Featuring Clinical Trials in Mitochondrial Disease
2024-11-28 16:19	C:TTI	0.68	News Release200	Thiogenesis attains DTC eligibility in the U.S.
2024-11-19 10:41	C:TTI	0.61	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-11-19 10:40	C:TTI	0.61	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-11-04 17:14	C:TTI	0.60	News Release200	Thiogenesis receives patent in Europe
2024-09-27 18:49	C:TTI	0.68	News Release200	Thiogenesis hires Triomphe for IR services
2024-09-17 09:31	C:TTI	0.70	News Release200	Thiogenesis Announces Presentation at 3rd Annual Leigh Syndrome Symposium
2024-08-23 14:38	C:TTI	0.73	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-08-23 14:38	C:TTI	0.73	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-08-20 16:50	C:TTI	0.74	News Release200	Thiogenesis signs agreement with UCSD
2024-07-18 16:43	C:TTI	0.74	News Release200	Thiogenesis signs research deal for its Leigh compound
2024-05-24 12:51	C:TTI	0.71	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-05-24 12:51	C:TTI	0.71	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-04-29 09:24	C:TTI	0.75	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-04-29 09:24	C:TTI	0.75	SEDAR MD & A815	SEDAR MD & A